Ironwood Pharmaceuticals, Inc. (IRWD)
3.64
-0.12
(-3.19%)
USD |
NASDAQ |
Oct 02, 16:00
3.64
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Price : 3.64 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 3.74 | 3.796 | 3.58 | 3.64 | 2.701M |
| Oct 01, 2026 | 3.95 | 3.97 | 3.735 | 3.76 | 2.643M |
| Sep 30, 2026 | 4.16 | 4.17 | 3.96 | 3.97 | 1.662M |
| Sep 29, 2026 | 4.12 | 4.17 | 4.08 | 4.16 | 1.233M |
| Sep 28, 2026 | 4.09 | 4.17 | 4.04 | 4.12 | 1.963M |
| Sep 25, 2026 | 4.22 | 4.25 | 4.10 | 4.13 | 1.320M |
| Sep 24, 2026 | 4.23 | 4.260 | 4.05 | 4.19 | 1.746M |
| Sep 23, 2026 | 4.50 | 4.536 | 4.25 | 4.27 | 1.658M |
| Sep 22, 2026 | 4.46 | 4.59 | 4.395 | 4.525 | 3.428M |
| Sep 21, 2026 | 4.39 | 4.595 | 4.30 | 4.41 | 2.415M |
| Sep 18, 2026 | 4.20 | 4.385 | 4.17 | 4.36 | 7.691M |
| Sep 17, 2026 | 4.27 | 4.48 | 4.20 | 4.23 | 3.487M |
| Sep 16, 2026 | 4.07 | 4.24 | 4.06 | 4.17 | 1.313M |
| Sep 15, 2026 | 4.18 | 4.18 | 4.045 | 4.06 | 1.125M |
| Sep 14, 2026 | 4.10 | 4.185 | 4.082 | 4.17 | 1.253M |
| Sep 11, 2026 | 4.03 | 4.105 | 3.94 | 4.08 | 1.250M |
| Sep 10, 2026 | 4.03 | 4.05 | 3.94 | 3.97 | 1.174M |
| Sep 09, 2026 | 4.14 | 4.16 | 4.035 | 4.07 | 1.477M |
| Sep 08, 2026 | 4.25 | 4.27 | 4.075 | 4.17 | 2.276M |
| Sep 04, 2026 | 4.26 | 4.33 | 4.22 | 4.26 | 829291.0 |
| Sep 03, 2026 | 4.45 | 4.48 | 4.275 | 4.29 | 1.133M |
| Sep 02, 2026 | 4.31 | 4.475 | 4.26 | 4.41 | 2.432M |
| Sep 01, 2026 | 4.19 | 4.315 | 4.18 | 4.27 | 1.456M |
| Aug 31, 2026 | 4.13 | 4.26 | 4.015 | 4.25 | 1.670M |
| Aug 28, 2026 | 4.20 | 4.21 | 4.08 | 4.13 | 1.519M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Viking Therapeutics, Inc. | 29.94 |
| Inovio Pharmaceuticals, Inc. | 1.16 |
| MediciNova, Inc. | 1.78 |
| Rigel Pharmaceuticals, Inc. | 47.15 |
| AbbVie, Inc. | 262.82 |
Price Related Metrics
| PE Ratio | 4.747 |
| PS Ratio | 1.576 |
| Price to Free Cash Flow | 3.306 |
| Earnings Yield | 21.07% |
| Market Cap | 601.47M |
| Operating PE Ratio | 2.598 |
| Normalized PE Ratio | 4.702 |